The Journal of Immunology, Vol 132, Issue 6 3197-3204, Copyright © 1984 by American Association of Immunologists

ARTICLES

Purification and properties of cytoplasmic granules from cytotoxic rat LGL tumors

PJ Millard, MP Henkart, CW Reynolds and PA Henkart

To evaluate the role of NK cell granules in the lytic activity of NK cells, cytoplasmic granules of rat NK tumors were purified by centrifugation of the cell homogenates in a Percoll gradient. Analysis of such gradients showed a band of light-scattering material near the bottom of the tube; assay of gradient fractions for lytic activity against SRBC showed a potent lytic activity giving a sharp peak in this region. Complete lysis of SRBC was achieved with less than 1 microgram/ml protein of the most active fractions. Examination in the electron microscope showed that a pool of fractions containing lytic activity consisted of pure cytoplasmic granules showing similar morphology to those found in the LGL tumors. The lytic band was associated with a peak in the activity of four different lysosomal enzymes. Analysis of Percoll gradient fractions showed that marker enzymes for mitochondria, plasma membrane, and cytosol were well separated from this activity peak. Analysis of the Percoll gradient fractions by SDS gel electrophoresis showed that this granule fraction was free of contamination of proteins from other parts of the gradient. The granules contained major protein bands of 62, 58, 30, 29, and 28 kilodaltons. In addition to protein, the purified granule fractions contain hexose and uronic acid, but no nucleic acids or phospholipids were detected in chemical assays. Major amounts of chymotryptic, tryptic, and elastase activities were not present, nor were peroxidase or lysozyme activities detectable in substantial amounts. These data show that NK tumor cell cytoplasmic granules contain a potent lytic activity and have biochemical properties that distinguish them from granules present in granulocytes and mast cells.

This article has been cited by other articles:

				K. Oshima, G. Cui, T. Tung, O. Okotie, H. Laks, and L. Sen Exogenous IL-10 overexpression reduces perforin production by activated allogenic CD8+ cells and prolongs cardiac allograft survival Am J Physiol Heart Circ Physiol, January 1, 2007; 292(1): H277 - H284. [Abstract] [Full Text] [PDF]

				L. Shi, D. Keefe, E. Durand, H. Feng, D. Zhang, and J. Lieberman Granzyme B Binds to Target Cells Mostly by Charge and Must Be Added at the Same Time as Perforin to Trigger Apoptosis J. Immunol., May 1, 2005; 174(9): 5456 - 5461. [Abstract] [Full Text] [PDF]

				I. Voskoboinik, M.-C. Thia, A. De Bono, K. Browne, E. Cretney, J. T. Jackson, P. K. Darcy, S. M. Jane, M. J. Smyth, and J. A. Trapani The Functional Basis for Hemophagocytic Lymphohistiocytosis in a Patient with Co-inherited Missense Mutations in the Perforin (PFN1) Gene J. Exp. Med., September 20, 2004; 200(6): 811 - 816. [Abstract] [Full Text] [PDF]

				S. A. Fraser, R. Karimi, M. Michalak, and D. Hudig Perforin Lytic Activity Is Controlled by Calreticulin J. Immunol., April 15, 2000; 164(8): 4150 - 4155. [Abstract] [Full Text] [PDF]

				V. ARNOLD, S. BALKOW, R. STAATS, H. MATTHYS, W. LUTTMANN, and J. C. VIRCHOW Jr. Increase in Perforin-positive Peripheral Blood Lymphocytes in Extrinsic and Intrinsic Asthma Am. J. Respir. Crit. Care Med., January 1, 2000; 161(1): 182 - 186. [Abstract] [Full Text]

				J. Spielman, R. K. Lee, and E. R. Podack Perforin/Fas-Ligand Double Deficiency Is Associated with Macrophage Expansion and Severe Pancreatitis J. Immunol., December 15, 1998; 161(12): 7063 - 7070. [Abstract] [Full Text] [PDF]

				O. Chertov, H. Ueda, L. L. Xu, K. Tani, W. J. Murphy, J. M. Wang, O.M. Z. Howard, T. J. Sayers, and J. J. Oppenheim Identification of Human Neutrophil-derived Cathepsin G and Azurocidin/CAP37 as Chemoattractants for Mononuclear Cells and Neutrophils J. Exp. Med., August 29, 1997; 186(5): 739 - 747. [Abstract] [Full Text] [PDF]

				O. Chertov, D. F. Michiel, L. Xu, J. M. Wang, K. Tani, W. J. Murphy, D. L. Longo, D. D. Taub, and J. J. Oppenheim Identification of Defensin-1, Defensin-2, and CAP37/Azurocidin as T-cell Chemoattractant Proteins Released from Interleukin-8-stimulated Neutrophils J. Biol. Chem., February 9, 1996; 271(6): 2935 - 2940. [Abstract] [Full Text] [PDF]

				J. Burkhardt, J. McIlvain, M. Sheetz, and Y Argon Lytic granules from cytotoxic T cells exhibit kinesin-dependent motility on microtubules in vitro J. Cell Sci., January 1, 1993; 104(1): 151 - 162. [Abstract] [PDF]

				J. Young, Z. Cohn, and E. Podack The ninth component of complement and the pore-forming protein (perforin 1) from cytotoxic T cells: structural, immunological, and functional similarities Science, July 11, 1986; 233(4760): 184 - 190. [Abstract] [PDF]